PI3R4_HUMAN - dbPTM
PI3R4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PI3R4_HUMAN
UniProt AC Q99570
Protein Name Phosphoinositide 3-kinase regulatory subunit 4
Gene Name PIK3R4
Organism Homo sapiens (Human).
Sequence Length 1358
Subcellular Localization Late endosome . Cytoplasmic vesicle, autophagosome . Membrane
Lipid-anchor . As component of the PI3K complex I localized to pre-autophagosome structures. As component of the PI3K complex II localized predominantly to endosomes. Localizes also to d
Protein Description Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2. [PubMed: 20643123]
Protein Sequence MGNQLAGIAPSQILSVESYFSDIHDFEYDKSLGSTRFFKVARAKHREGLVVVKVFAIQDPTLPLTSYKQELEELKIRLNSAQNCLPFQKASEKASEKAAMLFRQYVRDNLYDRISTRPFLNNIEKRWIAFQILTAVDQAHKSGVRHGDIKTENVMVTSWNWVLLTDFASFKPTYLPEDNPADFNYFFDTSRRRTCYIAPERFVDGGMFATELEYMRDPSTPLVDLNSNQRTRGELKRAMDIFSAGCVIAELFTEGVPLFDLSQLLAYRNGHFFPEQVLNKIEDHSIRELVTQMIHREPDKRLEAEDYLKQQRGNAFPEIFYTFLQPYMAQFAKETFLSADERILVIRKDLGNIIHNLCGHDLPEKAEGEPKENGLVILVSVITSCLQTLKYCDSKLAALELILHLAPRLSVEILLDRITPYLLHFSNDSVPRVRAEALRTLTKVLALVKEVPRNDINIYPEYILPGIAHLAQDDATIVRLAYAENIALLAETALRFLELVQLKNLNMENDPNNEEIDEVTHPNGNYDTELQALHEMVQQKVVTLLSDPENIVKQTLMENGITRLCVFFGRQKANDVLLSHMITFLNDKNDWHLRGAFFDSIVGVAAYVGWQSSSILKPLLQQGLSDAEEFVIVKALYALTCMCQLGLLQKPHVYEFASDIAPFLCHPNLWIRYGAVGFITVVARQISTADVYCKLMPYLDPYITQPIIQIERKLVLLSVLKEPVSRSIFDYALRSKDITSLFRHLHMRQKKRNGSLPDCPPPEDPAIAQLLKKLLSQGMTEEEEDKLLALKDFMMKSNKAKANIVDQSHLHDSSQKGVIDLAALGITGRQVDLVKTKQEPDDKRARKHVKQDSNVNEEWKSMFGSLDPPNMPQALPKGSDQEVIQTGKPPRSESSAGICVPLSTSSQVPEVTTVQNKKPVIPVLSSTILPSTYQIRITTCKTELQQLIQQKREQCNAERIAKQMMENAEWESKPPPPGWRPKGLLVAHLHEHKSAVNRIRVSDEHSLFATCSNDGTVKIWNSQKMEGKTTTTRSILTYSRIGGRVKTLTFCQGSHYLAIASDNGAVQLLGIEASKLPKSPKIHPLQSRILDQKEDGCVVDMHHFNSGAQSVLAYATVNGSLVGWDLRSSSNAWTLKHDLKSGLITSFAVDIHQCWLCIGTSSGTMACWDMRFQLPISSHCHPSRARIRRLSMHPLYQSWVIAAVQGNNEVSMWDMETGDRRFTLWASSAPPLSELQPSPHSVHGIYCSPADGNPILLTAGSDMKIRFWDLAYPERSYVVAGSTSSPSVSYYRKIIEGTEVVQEIQNKQKVGPSDDTPRRGPESLPVGHHDIITDVATFQTTQGFIVTASRDGIVKVWK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2N-myristoyl glycine------MGNQLAGIA
------CCCCCCCCC
41.73-
2Myristoylation------MGNQLAGIA
------CCCCCCCCC
41.738999962
39UbiquitinationLGSTRFFKVARAKHR
CCCCCHHHHHHHHCC
32.0727667366
61PhosphorylationVFAIQDPTLPLTSYK
EEEECCCCCCCCCHH
49.6621406692
65PhosphorylationQDPTLPLTSYKQELE
CCCCCCCCCHHHHHH
28.2421406692
66PhosphorylationDPTLPLTSYKQELEE
CCCCCCCCHHHHHHH
37.7121406692
67PhosphorylationPTLPLTSYKQELEEL
CCCCCCCHHHHHHHH
16.0821406692
68UbiquitinationTLPLTSYKQELEELK
CCCCCCHHHHHHHHH
36.7421906983
75UbiquitinationKQELEELKIRLNSAQ
HHHHHHHHHHHHHHC
29.1227667366
89UbiquitinationQNCLPFQKASEKASE
CCCCCHHHHHHHHHH
55.0121963094
93UbiquitinationPFQKASEKASEKAAM
CHHHHHHHHHHHHHH
55.5122817900
97UbiquitinationASEKASEKAAMLFRQ
HHHHHHHHHHHHHHH
38.6621906983
111PhosphorylationQYVRDNLYDRISTRP
HHHHHHHHHHHCCCH
14.9424043423
115PhosphorylationDNLYDRISTRPFLNN
HHHHHHHCCCHHHHH
21.1824043423
116PhosphorylationNLYDRISTRPFLNNI
HHHHHHCCCHHHHHH
39.7324043423
169PhosphorylationVLLTDFASFKPTYLP
EEEECHHHCCCCCCC
33.5224719451
210PhosphorylationVDGGMFATELEYMRD
CCCCCCEEHHHCCCC
29.8228796482
214PhosphorylationMFATELEYMRDPSTP
CCEEHHHCCCCCCCC
15.2928796482
219PhosphorylationLEYMRDPSTPLVDLN
HHCCCCCCCCCCCCC
47.1228796482
220PhosphorylationEYMRDPSTPLVDLNS
HCCCCCCCCCCCCCC
26.4828796482
280UbiquitinationFPEQVLNKIEDHSIR
CHHHHHHHHCCCCHH
43.2221906983
300UbiquitinationMIHREPDKRLEAEDY
HHHCCCCHHHCHHHH
70.3829967540
309UbiquitinationLEAEDYLKQQRGNAF
HCHHHHHHHHHCCCC
37.8521906983
338PhosphorylationFAKETFLSADERILV
HHHHHHCCCCCEEEE
29.50-
348UbiquitinationERILVIRKDLGNIIH
CEEEEEECHHHHHHH
46.2929967540
419PhosphorylationEILLDRITPYLLHFS
HHHHHHHHHHHHHCC
13.5329209046
421PhosphorylationLLDRITPYLLHFSND
HHHHHHHHHHHCCCC
17.1629209046
426PhosphorylationTPYLLHFSNDSVPRV
HHHHHHCCCCCCHHH
29.0429209046
429PhosphorylationLLHFSNDSVPRVRAE
HHHCCCCCCHHHHHH
37.9729209046
443UbiquitinationEALRTLTKVLALVKE
HHHHHHHHHHHHHHC
38.0621963094
449UbiquitinationTKVLALVKEVPRNDI
HHHHHHHHCCCCCCC
54.5721906983
459PhosphorylationPRNDINIYPEYILPG
CCCCCCCCHHHHCCC
5.8724043423
462PhosphorylationDINIYPEYILPGIAH
CCCCCHHHHCCCHHH
11.8524043423
476PhosphorylationHLAQDDATIVRLAYA
HHHCCCCHHHHHHHH
27.3124043423
482PhosphorylationATIVRLAYAENIALL
CHHHHHHHHHHHHHH
21.0224043423
492PhosphorylationNIALLAETALRFLEL
HHHHHHHHHHHHHHH
25.9424043423
543PhosphorylationMVQQKVVTLLSDPEN
HHHHHHHHHHCCHHH
25.6020068231
546PhosphorylationQKVVTLLSDPENIVK
HHHHHHHCCHHHHHH
54.9920068231
553UbiquitinationSDPENIVKQTLMENG
CCHHHHHHHHHHHCC
33.4921906983
579PhosphorylationKANDVLLSHMITFLN
HHHHHHHHHHHHHHC
13.5726270265
583PhosphorylationVLLSHMITFLNDKND
HHHHHHHHHHCCCCC
17.9426270265
614PhosphorylationYVGWQSSSILKPLLQ
HHCCCCHHHHHHHHH
36.8724719451
673PhosphorylationHPNLWIRYGAVGFIT
CCCEEEECCCHHHHE
10.5819664994
680PhosphorylationYGAVGFITVVARQIS
CCCHHHHEEEEECCC
13.48-
698PhosphorylationVYCKLMPYLDPYITQ
HHHHHHHHCCCCCCC
15.1220071362
713UbiquitinationPIIQIERKLVLLSVL
CHHHHHHHHHHHHHH
30.11-
731PhosphorylationVSRSIFDYALRSKDI
CCHHHHHHHHHCCCH
9.2228152594
736UbiquitinationFDYALRSKDITSLFR
HHHHHHCCCHHHHHH
46.87-
740PhosphorylationLRSKDITSLFRHLHM
HHCCCHHHHHHHHHH
26.3324719451
772UbiquitinationPAIAQLLKKLLSQGM
HHHHHHHHHHHHCCC
50.3922817900
773MalonylationAIAQLLKKLLSQGMT
HHHHHHHHHHHCCCC
55.4126320211
773UbiquitinationAIAQLLKKLLSQGMT
HHHHHHHHHHHCCCC
55.4121906983
776PhosphorylationQLLKKLLSQGMTEEE
HHHHHHHHCCCCHHH
34.8123401153
780PhosphorylationKLLSQGMTEEEEDKL
HHHHCCCCHHHHHHH
47.25-
786UbiquitinationMTEEEEDKLLALKDF
CCHHHHHHHHHHHHH
48.9922817900
791UbiquitinationEDKLLALKDFMMKSN
HHHHHHHHHHHHHCC
43.2321906983
796UbiquitinationALKDFMMKSNKAKAN
HHHHHHHHCCHHHCC
38.8022817900
797PhosphorylationLKDFMMKSNKAKANI
HHHHHHHCCHHHCCC
26.1829255136
801UbiquitinationMMKSNKAKANIVDQS
HHHCCHHHCCCCCHH
43.5029967540
808PhosphorylationKANIVDQSHLHDSSQ
HCCCCCHHHCCCCCC
24.4530266825
813PhosphorylationDQSHLHDSSQKGVID
CHHHCCCCCCCCCCH
24.7430266825
814PhosphorylationQSHLHDSSQKGVIDL
HHHCCCCCCCCCCHH
41.8030266825
816AcetylationHLHDSSQKGVIDLAA
HCCCCCCCCCCHHHH
58.0325953088
816UbiquitinationHLHDSSQKGVIDLAA
HCCCCCCCCCCHHHH
58.0329967540
835UbiquitinationGRQVDLVKTKQEPDD
CCEEEEEECCCCCCH
58.2527667366
836PhosphorylationRQVDLVKTKQEPDDK
CEEEEEECCCCCCHH
30.4028857561
837UbiquitinationQVDLVKTKQEPDDKR
EEEEEECCCCCCHHH
47.1224816145
843AcetylationTKQEPDDKRARKHVK
CCCCCCHHHHHHHHH
56.1726051181
847UbiquitinationPDDKRARKHVKQDSN
CCHHHHHHHHHCCCC
52.3322817900
850UbiquitinationKRARKHVKQDSNVNE
HHHHHHHHCCCCCCH
48.3721906983
853PhosphorylationRKHVKQDSNVNEEWK
HHHHHCCCCCCHHHH
39.9422167270
861PhosphorylationNVNEEWKSMFGSLDP
CCCHHHHHHHCCCCC
22.0321082442
865PhosphorylationEWKSMFGSLDPPNMP
HHHHHHCCCCCCCCC
20.5225159151
886PhosphorylationSDQEVIQTGKPPRSE
CCHHHHHCCCCCCCC
35.7326074081
888UbiquitinationQEVIQTGKPPRSESS
HHHHHCCCCCCCCCC
56.0621906983
892PhosphorylationQTGKPPRSESSAGIC
HCCCCCCCCCCCCEE
47.8330278072
894PhosphorylationGKPPRSESSAGICVP
CCCCCCCCCCCEEEE
27.0830278072
895PhosphorylationKPPRSESSAGICVPL
CCCCCCCCCCEEEEC
26.8530576142
903PhosphorylationAGICVPLSTSSQVPE
CCEEEECCCCCCCCC
21.8526074081
904PhosphorylationGICVPLSTSSQVPEV
CEEEECCCCCCCCCE
39.8326074081
905PhosphorylationICVPLSTSSQVPEVT
EEEECCCCCCCCCEE
18.5226074081
906PhosphorylationCVPLSTSSQVPEVTT
EEECCCCCCCCCEEE
34.9726074081
912PhosphorylationSSQVPEVTTVQNKKP
CCCCCCEEEECCCCC
21.4220068231
913PhosphorylationSQVPEVTTVQNKKPV
CCCCCEEEECCCCCC
25.8520068231
918UbiquitinationVTTVQNKKPVIPVLS
EEEECCCCCCEEEEC
52.66-
925PhosphorylationKPVIPVLSSTILPST
CCCEEEECCCCCCCC
26.1830266825
926PhosphorylationPVIPVLSSTILPSTY
CCEEEECCCCCCCCE
18.4630266825
927PhosphorylationVIPVLSSTILPSTYQ
CEEEECCCCCCCCEE
24.1330266825
931PhosphorylationLSSTILPSTYQIRIT
ECCCCCCCCEEEEEE
35.9820068231
932PhosphorylationSSTILPSTYQIRITT
CCCCCCCCEEEEEEE
19.9427251275
933PhosphorylationSTILPSTYQIRITTC
CCCCCCCEEEEEEEC
13.2827642862
938PhosphorylationSTYQIRITTCKTELQ
CCEEEEEEECHHHHH
19.1220068231
939PhosphorylationTYQIRITTCKTELQQ
CEEEEEEECHHHHHH
15.0520068231
941UbiquitinationQIRITTCKTELQQLI
EEEEEECHHHHHHHH
42.83-
942PhosphorylationIRITTCKTELQQLIQ
EEEEECHHHHHHHHH
44.04-
951AcetylationLQQLIQQKREQCNAE
HHHHHHHHHHHHCHH
41.3425953088
951MalonylationLQQLIQQKREQCNAE
HHHHHHHHHHHHCHH
41.3426320211
951UbiquitinationLQQLIQQKREQCNAE
HHHHHHHHHHHHCHH
41.3422817900
962UbiquitinationCNAERIAKQMMENAE
HCHHHHHHHHHHHCC
36.0329967540
973UbiquitinationENAEWESKPPPPGWR
HHCCCCCCCCCCCCC
50.4529967540
993UbiquitinationVAHLHEHKSAVNRIR
EEEHHHCCCHHCEEE
36.8129967540
1018UbiquitinationCSNDGTVKIWNSQKM
ECCCCCEEEEECCCC
41.6729967540
1024AcetylationVKIWNSQKMEGKTTT
EEEEECCCCCCCCCC
38.4526051181
1034PhosphorylationGKTTTTRSILTYSRI
CCCCCCHHHHEEEEE
21.6220068231
1037PhosphorylationTTTRSILTYSRIGGR
CCCHHHHEEEEECCE
20.1320068231
1038PhosphorylationTTRSILTYSRIGGRV
CCHHHHEEEEECCEE
7.7820068231
1039PhosphorylationTRSILTYSRIGGRVK
CHHHHEEEEECCEEE
16.5220068231
1074PhosphorylationQLLGIEASKLPKSPK
EEEEEEHHHCCCCCC
23.18-
1079PhosphorylationEASKLPKSPKIHPLQ
EHHHCCCCCCCCCCH
29.5019369195
1081UbiquitinationSKLPKSPKIHPLQSR
HHCCCCCCCCCCHHH
61.8229967540
1272PhosphorylationIRFWDLAYPERSYVV
EEEEECCCCCCEEEE
16.96-
1276PhosphorylationDLAYPERSYVVAGST
ECCCCCCEEEEECCC
22.1823663014
1277PhosphorylationLAYPERSYVVAGSTS
CCCCCCEEEEECCCC
12.7423663014
1282PhosphorylationRSYVVAGSTSSPSVS
CEEEEECCCCCCCHH
18.5123663014
1283PhosphorylationSYVVAGSTSSPSVSY
EEEEECCCCCCCHHH
32.1023663014
1284PhosphorylationYVVAGSTSSPSVSYY
EEEECCCCCCCHHHH
41.7823663014
1285PhosphorylationVVAGSTSSPSVSYYR
EEECCCCCCCHHHHH
22.6823663014
1287PhosphorylationAGSTSSPSVSYYRKI
ECCCCCCCHHHHHHH
26.1623663014
1289PhosphorylationSTSSPSVSYYRKIIE
CCCCCCHHHHHHHHC
22.3023663014
1290PhosphorylationTSSPSVSYYRKIIEG
CCCCCHHHHHHHHCC
12.7223663014
1291PhosphorylationSSPSVSYYRKIIEGT
CCCCHHHHHHHHCCC
9.6423663014
1293UbiquitinationPSVSYYRKIIEGTEV
CCHHHHHHHHCCCHH
31.7322817900
1307UbiquitinationVVQEIQNKQKVGPSD
HHHHHHHCCCCCCCC
34.8121906983
1309UbiquitinationQEIQNKQKVGPSDDT
HHHHHCCCCCCCCCC
51.2522817900
1316PhosphorylationKVGPSDDTPRRGPES
CCCCCCCCCCCCCCC
24.5621082442

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PI3R4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PI3R4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PI3R4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of PI3R4_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PI3R4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Myristoylation
ReferencePubMed
"Characterization of p150, an adaptor protein for the humanphosphatidylinositol (PtdIns) 3-kinase. Substrate presentation byphosphatidylinositol transfer protein to the p150.PtdIns 3-kinasecomplex.";
Panaretou C., Domin J., Cockcroft S., Waterfield M.D.;
J. Biol. Chem. 272:2477-2485(1997).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 53-63; 333-343;540-554 AND 786-791, MYRISTOYLATION AT GLY-2, PHOSPHORYLATION,COFACTOR, TISSUE SPECIFICITY, AND INTERACTION WITH PIK3C3.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-808; SER-813; SER-814;SER-853; SER-861; SER-865; SER-892; SER-925 AND SER-1079, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-853; SER-865 ANDTHR-1316, AND MASS SPECTROMETRY.

TOP